We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





MEDLAB Middle East and Arab Health 2022 Edition Return as Co-Located Events for Healthcare and Laboratory Industries

By LabMedica International staff writers
Posted on 24 Jan 2022
Print article
Image: MEDLAB Middle East (Photo courtesy of Informa Markets)
Image: MEDLAB Middle East (Photo courtesy of Informa Markets)

Technology took centre stage at the 2022 edition of Arab Health and MEDLAB Middle East, the largest healthcare and laboratory exhibitions in the MENA region, organized by Informa Markets (London, UK).

The co-located events took place at the Dubai World Trade Centre from January 24-27 under the show themes of ‘United by business, forging ahead’ and ‘Connect with innovation that’s changing the face of diagnostics’. Both shows saw participants from nearly 160 countries and more than 60,000 attendees across the four days, with almost 4,000 exhibitors from the healthcare and laboratory industries.

More than 60 countries were represented, with over 20 dedicated country pavilions, making Arab Health and MEDLAB Middle East a genuinely global healthcare showcase. They included the UAE, Israel, Lebanon, Turkey, and a host of European countries such as the UK, Switzerland, Germany, Italy, France, Spain, Portugal, Slovenia, Hungary, Czech Republic, Poland, and Belgium. Russia, China, Taiwan, Japan, Korea, India, the US and Canada also had several exhibitors showcasing the latest technology and innovation through a range of healthcare products. Each pavilion hosted between 16 and 33 healthcare-related companies. In addition, the European Innovation Council Pavilion hosted 20 selected companies from across the healthcare landscape.

Underscoring the focus on technology, Arab Health 2022 featured the new Healthcare Transformation Zone which explored the latest tech advancements from global innovators and disruptors. The popular start-up competition, Innov8 Talks returned and featured 24 companies showcasing unique and innovative solutions. Rounding out the Transformation Zone was the launch of the Product Showcase segment, where a range of companies showcased ground-breaking innovations shaping the future of the healthcare and laboratory industries.

In another first for both events was the launch of the Future Health Summit. The high-level event was attended by over 150 senior government healthcare officials, CEOs and visionaries, from across the globe. As part of the Arab Health Congress, more than 550 regional and international speakers and over 2,500 delegates participated in 12 Continuing Medical Education (CME). With a total of nine conferences, MEDLAB Middle East Congress remains one of the largest CME accredited multi-track medical laboratory congresses globally, featuring over 100 renowned laboratory champions from around the world. Eight conferences took place live, in-person, and online, the new bonus track, Future of Lab.

"Arab Health and Medlab Middle East will once again reiterate the importance of the healthcare and laboratory industries as we continue to address the challenges posed by COVID-19 and provide a platform for developing solutions to overcome the pandemic," said Solenne Singer, Group Director for Informa Markets. "We have witnessed a clear uptick in demand from both buyers and exhibitors eager to meet in-person, to see firsthand the latest technology and innovation on the market, while also hearing from industry professionals from around the world on the latest trends and insights. This year, both events will be integral to ongoing global recovery, and we look forward to welcoming the industry to Dubai."

Related Links:
Informa Markets 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
All-in-one Molecular Diagnosis System
Panall 8000

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.